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See Article, pages 398–406The recent controversy on the respective place of liver biopsy and
non-invasive tools in chronic liver diseases has focused attention
on the quantitative evaluation of ﬁbrosis. As a basis for further
discussion that liver biopsy is the best available standard for
assessment of liver ﬁbrosis, the article of Gailhouste et al. [1] in
the present issue of the Journal of Hepatology shows that biopsy
can tell us much more than a score, providing additional useful
information on the texture of ﬁbrosis which might have clinical
relevance. Liver ﬁbrosis is the accumulation of newly synthesized
extracellular matrix (ECM) molecules within the liver. Several
ECM molecules have been characterized and ﬁbrillar collagen
(mainly isotype I and III) are among the most important [2].
These molecules auto-assemble into a characteristic triple helical
pattern that organize into highly stable ﬁbrillar units. These
ﬁbrillar structures serve as a scaffold for the deposition and orga-
nization of other ECMmolecules and are therefore of major phys-
iopathological importance in the process of liver ﬁbrosis
development [3].
To assess liver ﬁbrosis, pathologists normally utilize speciﬁc
stainingmethods thathighlightﬁbrous tissue.Masson’s trichrome,
Picrosirius red or reticulin stain are among the most commonly
used methods, each of which is based on a more or less well-char-
acterized chemical reaction. Although these staining methods
allow for the overall detection of ﬁbrosis, their biochemical speci-
ﬁcity is poor or even unknown. Immunohistochemical procedures
using antibodies directed against various ECM components allow
for the identiﬁcation of single ECM proteins; however, this
approach is limited by antibody speciﬁcity and the restrictive use
of frozen tissue sections for somecases.Anadditional disadvantage
is that immunohistochemistry is not a quantitative technique.
In this issue Gailhouste et al. propose an original approach for
the analysis of liver ﬁbrosis using a non-linear optical micros-
copy modality, i.e. multiphoton microscopy. Non-linear optical
microscopy has signiﬁcantly improved three-dimensional imag-
ing of biological tissues in recent years [4]. It enables the obser-
vation of endogenous signals such as Two-Photon Excitation
Fluorescence (TPEF) and Second Harmonic Generation (SHG) in
unstained samples and deep within the tissue sample [5]. In
short, while TPEF allows for the visualization of the liverJournal of Hepatology 20
*Tel.: +33 1 40 87 54 60, fax: +33 1 40 87 00 77.
E-mail address: pierre.bedossa@bjn.aphp.fr
pen access under CC BY-NC-ND license.background and lobular organization, the SHG displays the three-
dimensional architecture of ﬁbrillar collagen. The speciﬁcity of
SGH for ﬁbrillar collagen is based on its highly ordered supra-
molecular organization [6]. The apparent complexity of this
imaging technology combined with the high resolution and qual-
ity of images provided in this study should not reduce this article
to a technical achievement only. It is in fact a new vision into
liver ﬁbrosis evaluation. With this approach the authors were
able to visualize and quantify ﬁbrillar collagen at a high resolu-
tion scale in the context of its microenvironment without utiliz-
ing the conventional staining method that is followed by
formalin-ﬁxed parafﬁn-embedding. To validate the speciﬁcity of
the ECM components detected by the SHG, the authors compare
SHG images with immunohistochemical labeling and observe a
close relationship between Type I and III collagen isotypes and
the SHG signal, while immunostaining for non-ﬁbrillar collagen
did not co-localize. High penetration and accurate spatial resolu-
tion of multiphoton microscopy provided impressive images of a
3-D reconstruction of the ECM network arrangement in liver
parenchyma at a micrometer scale.
Why is this important? If clinical evidence of ﬁbrosis regres-
sion is present, the triple helix and organization of ﬁbrillar colla-
gen gives it high stability and, once deposited in the liver, it may
impair liver architecture permanently [7]. While obtaining a glo-
bal assessment of liver ﬁbrosis with the scoring system is impor-
tant, the evaluation of presence, amount, and distribution of
ﬁbrillar collagen in a liver biopsy might be crucial for predicting
prognosis of chronic liver diseases. However, it should be kept in
mind that formation of ﬁbrillar collagen is a late event in ﬁbro-
genesis. Evaluation of ﬁbrosis with SHG may only give a rather
restricted view of ﬁbrosis stages, possibly missing the early
stages of the process. Therefore, SHG should be considered as
an additional tool that can provide an added value by allowing
for the assessment of the relative amounts of ﬁbrillar collagen
within ﬁbrous tissue, and should be used in conjunction with
standard histopathology for ﬁbrosis scoring.
The physical properties of the ECM have recently been
assessed through stiffness evaluation with ultrasound (Fibroscan)
or magnetic resonance imaging. Although this approach appeared
relevant to screen for advanced liver ﬁbrosis, the correlation
between liver ﬁbrosis as assessed by the standard histopathology
scoring system and liver stiffness is relatively loose [8,9]. Intui-
tively, the high degree of reticulation of ﬁbrillar collagen might10 vol. 52 j 313–314
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directly impact liver stiffness. Therefore, studying the correlation
between the SHG index and liver stiffness might provide us with
a plethora of new information.
To validate this new method of evaluation of liver ﬁbrosis, the
authors compare the SHG index with the METAVIR score. Unsur-
prisingly, they found that the SHG index increased with the
METAVIR stage but that this increase was exponential rather than
linear. This exponential correlation is highly similar to the corre-
lation between METAVIR scores and stiffness as evaluated with
Fibroscan. The same is true for the wide range in SHG index
observed in cirrhotic patients which has also been reported when
stiffness evaluation is concerned in liver cirrhosis. These results
also support the possible correlation between liver stiffness and
relative composition of ECM in ﬁbrillar collagen as assessed with
the SGH index.
Gailhouste et al. underline the beneﬁt of a linear scale as pro-
vided by the SGH index by comparison to histological scoring sys-
tems since a continuous scale provides greater accuracy than a
semi-quantitative score. Morphometry is another method that
allows for a linear measurement of global liver ﬁbrosis on tissue
sections stained with PicroSirius red. Several studies have shown
that quantitation with morphometry also correlates with histo-
logical scoring of ﬁbrosis [10]. SHG and morphometry are both
automated methods that avoid the risk of inter-observer varia-
tion in evaluation of liver ﬁbrosis, a potential drawback of
semi-quantitative scoring systems which remains partly subjec-
tive and dependent on pathologist expertise [11]. Since both
techniques can be performed in the same biopsy, a correlation
between the evaluation of liver ﬁbrosis with morphometry and
SHG would also be useful in order to assess the extent of discrep-
ancies in ﬁbrosis quantiﬁcation with both methods.
Whether SHG or morphometry is concerned, these quantita-
tive approaches, although very accurate and linear, deserve fur-
ther commentaries. Firstly, sampling error which is related to
heterogeneity in ﬁbrosis distribution might become a relevant
drawback when the accuracy of the evaluation technique for
ﬁbrosis quantiﬁcation increases. Although this drawback is rather
limited when simple semi-quantitative scoring systems are con-
cerned (METAVIR or Ishak scores of ﬁbrosis), several studies have
shown that sampling errors become a relevant limit when accu-
rate techniques that evaluate ﬁbrosis along a linear scale are con-
cerned [12]. Second, the amount of ﬁbrosis, whether evaluated
through ﬁbrillar collagen (SGH) or global ﬁbrosis staining (Sirius
red), is only a part of the deleterious process that leads to cirrho-314 Journal of Hepatology 201sis. Architectural changes, vascular shunts, and liver cell regener-
ation are among the other associated features which might have a
signiﬁcant inﬂuence on the natural progression of liver disease.
They are also evaluated when pathologists score biopsies; how-
ever, these lesions are not considered when automated evalua-
tion is used.
Finally, SGH is clearly not a routine technique that is designed
to replace staging of ﬁbrosis with scoring systems but appears
rather as a complement to semi-quantitative histopathology of
ﬁbrosis. At present, the major challenge is to demonstrate that
the SGH index might provide an added value in the prediction
of liver disease prognosis speciﬁcally with respect to ﬁbrosis
regression.References
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